Tianjin's RMB 30 Billion Biomedical Industry Expands Innovative Capacity
This article was originally published in PharmAsia News
Executive Summary
Tianjin's biomedical industry output value in 2009 exceeded RMB 30 million, boosted by significant gains in innovative capacity in recent years